RTO

Rentokil Initial plc: 2026 Interim Results Summary

Business Context and Reporting Period

This Form 6-K reports the unaudited interim financial results for Rentokil Initial plc for the six months ended 30 June 2026. The company operates globally in Pest Control and Hygiene & Wellbeing services across approximately 90 countries. The reporting period covers the first half of the 2026 fiscal year, with results issued on 30 July 2026.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Group organic revenue growth of 3.6% was driven by North America (3.7%) and International (3.5%). International growth accelerated in Q2 to 4.2%.
• Profitability: Adjusted Operating Profit grew 6.6% at constant currency. North America Adjusted Operating Profit grew 10.2%, while International grew 4.3%.
• Debt Reduction: Net debt decreased by $645m to $3,575m, bringing the Net Debt to Adjusted EBITDA ratio to 2.4x, within the target range of 2.0x–2.5x for the first time since the Terminix acquisition.
• Transformation Costs: One-off and adjusting items totaled $112m, including $38m for North America transformation and $9m for International transformation. An additional $47m provision was made for termite damage claims.
• Dividend: Interim dividend increased 8.0% to 4.48 cents per share.

Guidance, Outlook, and Management Commentary

Outlook: Management maintains its FY 2026 profit guidance, expecting results in line with current market expectations despite some weakness in North America Residential lead flow observed in late Q2 and July.

Strategic Priorities: CEO Mike Duffy outlined three key priorities to drive sustainable organic growth:

1. Focus on the Customer: Enhancing the customer lifetime journey to improve satisfaction, sales, and retention.
2. Sales and Operational Excellence: Standardizing the branch operating model and improving execution, including separating leadership for US Residential and Commercial businesses.
3. Business Simplification: Reducing complexity in the global operating model and optimizing the cost base to fund reinvestment, primarily in North America.

Unusual Items & Risks:

• Termite Provisions: The legacy termite provision increased to $364m. The total provision stands at $392m, with an estimated 2026 cash outflow of $115m–$125m.
• North America Margin Target: The company is retiring its North America margin target of 20% in 2027 to prioritize volume growth and reinvestment.
• Principal Risks: Key risks include integration of acquisitions, macroeconomic volatility, cyber security, and the ongoing uncertainty regarding termite damage claims.

Investor Verification Checklist

• Termite Liability Sensitivity: Verify the assumptions regarding claim rates, claim values, and discount rates used to calculate the $392m provision, noting the sensitivity to inflation and litigation trends.
• North America Lead Flow: Monitor the trend in North America Residential lead flow, which showed weakness in late Q2 and July, to assess the validity of the unchanged FY 2026 profit guidance.
• Transformation ROI: Track the realization of the $90m annualized gross savings run rate in North America against the $38m incurred costs to ensure margin improvement targets are met.
• Organic Growth Quality: Analyze the split between contract revenue growth (2.6% in NA Pest Control) and jobbing revenue growth (5.7% in NA Pest Control) to understand the sustainability of the 3.6% organic growth rate.
• Debt Maturity Profile: Review the $1.0bn revolving credit facility maturing in October 2029 and the bond debt structure to confirm liquidity headroom remains adequate under downside scenarios.